Startup Empatica says its Embrace smart watch is now approved by the US Food and Drug Administration as a medical device—a rare designation for a wearable.
Winning approval: The $249 watch detects when a wearer is having a convulsive seizure and lets family members know via a smartphone app. In a 135-patient trial as part of the FDA approval, epilepsy patients suffered 40 seizures, and the watch’s algorithm spotted them all.
Why it matters: There are 3.4 million people in the US with epilepsy. Worldwide, the figure is roughly 50 million. Keeping track of when seizures happen can help get patients medical attention and aid doctors in monitoring their condition over time.
What it means for wearables: The approval allows the firm to make medical claims about the device, and could enable people with epilepsy to have insurance pay for it. It may also encourage doctors and hospitals to use such devices, says Rosalind Picard, Empatica’s cofounder and chief scientist.
How the Supreme Court ruling on Section 230 could end Reddit as we know it
As tech companies scramble in anticipation of a major ruling, some experts say community moderation online could be on the chopping block.
2022’s seismic shift in US tech policy will change how we innovate
Three bills investing hundreds of billions into technological development could change the way we think about government’s role in growing prosperity.
Mass-market military drones: 10 Breakthrough Technologies 2023
Turkish-made aircraft like the TB2 have dramatically expanded the role of drones in warfare.
We’re witnessing the brain death of Twitter
An analysis of Musk’s tweets shows him at the center of conversations once kept on the fringes of Twitter.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.